Major General (Ret.) Barbara R. Holcomb Joins Board at Humanetics
Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, has announced the addition of Major General (Ret.)
- Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, has announced the addition of Major General (Ret.)
- Barbara R. Holcomb, RN, BSN, MSN to its board of directors.
- “General Holcomb brings a wealth of knowledge and relevant experience that strengthens our Board,” said Ronald J. Zenk, Chief Executive Officer at Humanetics.
- Humanetics is currently working under a contract with DOD to position BIO 300 for Emergency Use.